膜杰作
Star Staining
ViruStop
Aneuro
ComboX
ActiveMax
GENPower
ClinMax
> 【SLC1A5】
SLC1A5信息
英文名称：Neutral amino acid transporter B(0)
中文名称：
靶点别称：ATB(0)，Baboon M7 virus receptor，RD114/simian type D retrovirus receptor，Sodium-dependent neutral amino acid transporter type 2，Solute carrier family 1 member 5，ASCT2，M7V1，RDRC
中文名称：
靶点别称：ATB(0)，Baboon M7 virus receptor，RD114/simian type D retrovirus receptor，Sodium-dependent neutral amino acid transporter type 2，Solute carrier family 1 member 5，ASCT2，M7V1，RDRC
上市药物数量：0
临床药物数量：1
最高研发阶段：临床前
临床药物数量：1
最高研发阶段：临床前
SLC1A5 分子别名
ASCT2,M7V1,RDR,RDRC,ATB(0),AAAT,ASCT2M7VS1,M7V1ATBO,R16,RD114,RDRCFLJ31068
SLC1A5 分子背景
Sodium-dependent amino acids transporter(SLC1A5) that has a broad substrate specificity, with a preference for zwitterionic amino acids. It accepts as substrates all neutral amino acids, including glutamine, asparagine, and branched-chain and aromatic amino acids, and excludes methylated, anionic, and cationic amino acids. Through binding of the fusogenic protein syncytin-1/ERVW-1 may mediate trophoblasts syncytialization, the spontaneous fusion of their plasma membranes, an essential process in placental development (PubMed:10708449, PubMed:23492904).
SLC1A5 前沿进展
SLC1A5临床药物信息
| 英文名称 | 研发代码 | 研发阶段 | 公司 | 适应症 | 临床试验 |
|---|
